Company Spotlight: Ever Fortune.AI ETT-XR-100 - AI Triage for Misplaced Endotracheal Tubes

NOV 20, 202613 MIN

Description

This episode unpacks the FDA 510(k) clearance summary for Ever Fortune.AI's EFAI ETTXR system, an AI tool designed to flag malpositioned endotracheal tubes on adult chest X-rays. We break down the clinical testing data, the algorithm's specific measurement thresholds, and crucial limitations regarding esophageal intubation and double lumen tubes. Key points The EFAI ETTXR is a radiological triage software that analyzes adult chest X-rays to flag suspected vertically malpositioned endotracheal tubes in relation to the carina. In a retrospective, multisite clinical validation study of 940 studies, the device demonstrated a sensitivity of 0.890 and a specificity of 0.935. The software triggers a flag if the endotracheal tube tip is assessed as more than 7 cm above the carina, less than 3 cm above the carina, or below the carina. The device provides a passive notification via a text-based JSON file to prioritize worklists, but does not highlight or mark the original image. Crucial limitations include the inability to detect esophageal intubation, a lack of awareness of patient positioning, and the potential to trigger false alerts for properly positioned double lumen tubes. Source: FDA 510(k) summary K242821: EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) (Ever Fortune.AI) - U.S. Food and Drug Administration, 2025 This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Company: Ever Fortune.AI · Product: EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) · FDA 510(k) K242821 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-ever-fortune-ai-ett-xr-100-ai-triage-for-misplaced-e-396e7d